Strongyloides IgM ELISA Kit

The Strongyloides IgM ELISA Kit is a semi-quantitative enzyme-linked immunosorbent assay (ELISA) designed to detect IgM antibodies specific to Strongyloides stercoralis in human serum or plasma samples. This kit is intended for early diagnosis of acute infections and is to be used by trained medical technologists.

Strongyloides stercoralis is an intestinal nematode with global distribution, particularly prevalent in tropical and subtropical regions. Infection usually manifests as mild intestinal symptoms, such as diarrhea. However, in severe cases, the parasite can migrate to extra-intestinal sites, causing septic shock and meningitis, especially in immunocompromised individuals.

This kit uses L3 stage Strongyloides antigens coated on microplates to detect specific IgM antibodies. The assay provides reliable results through a strong colorimetric reaction, which can be interpreted visually or using an ELISA reader. The kit is suitable for clinical diagnosis and epidemiological studies, supporting early detection and prevention efforts in high-risk populations.

Strongyloides IgM ELISA Kit

√  Early Detection: Identifies acute infections via IgM antibody detection.

√  High Sensitivity: Accurately detects low levels of IgM antibodies.

√  High Specificity: Optimized antigens minimize cross-reactivity.

√  Rapid Workflow: Efficient procedure for quick results.

√  Clear Results: Strong colorimetric response for visual or instrumental interpretation.

√  Stable Storage: Reagents remain stable at 2-8°C for long-term reliability.

√  Quality Assurance: Includes positive and negative controls for validation.

√  Versatile Application: Compatible with serum and plasma samples.

Strongyloides IgM ELISA Kit

√  Clinical Laboratories: Early screening and diagnosis of Strongyloides infections.

√  Public Health Centers: Epidemiological studies and screenings in endemic regions.

√  Immunocompromised Patient Management: Risk assessment for patients undergoing immunosuppressive therapy.

√  Parasitology Research Institutions: Supporting studies on the immunology and epidemiology of Strongyloides infections.

√  Remote Healthcare Facilities: Reliable diagnostic tools for resource-limited settings.

√  International Quarantine Services: Screening travelers and workers from high-risk regions.

√  Community Health Programs: Implementing prevention and control measures in endemic regions.

√  Travel Medicine Centers: Managing health risks for travelers to tropical and subtropical regions.